Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 26
- Registration Number
- NCT05298306
- Locations
- 🇦🇺
PARC Clinical Research, Adelaide, South Australia, Australia
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
- First Posted Date
- 2019-11-06
- Last Posted Date
- 2021-04-28
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 21
- Registration Number
- NCT04153409
- Locations
- 🇦🇺
Paratus Clinical Research, Central Coast, Kanwal, New South Wales, Australia
🇦🇺Paratus Clinical Research, Blacktown, Sydney, New South Wales, Australia
🇦🇺Emeritus Research, Camberwell, Victoria, Australia
Oral LAT8881 in Neuropathic Pain
Phase 2
Completed
- Conditions
- Post Herpetic Neuralgia (PHN)Neuropathic PainDiabetic Peripheral Neuropathy (DPN)
- Interventions
- Drug: Placebo
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Lateral Pharma Pty Ltd
- Target Recruit Count
- 53
- Registration Number
- NCT03865953
- Locations
- 🇦🇺
Paratus Clinical Research Kanwal, Kanwal, New South Wales, Australia
🇦🇺Paratus Clinical Research Blacktown, Sydney, New South Wales, Australia
🇦🇺AusTrials, Brisbane, Queensland, Australia
News
No news found